Described as both an anti- [42] and pro-apoptotic factor [43], very few and controversial results are reported in literature about TG2 role in metastatic melanoma, principally regarding its ability to remodel tumor microenvironment niche [42, 43]. The gene discussed is TGM2; the disease is neoplasm.